Literature DB >> 17434983

Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias.

Kyungmoo Ryu1, Li Li, Celeen M Khrestian, Naomichi Matsumoto, Jayakumar Sahadevan, Mary L Ruehr, David R Van Wagoner, Igor R Efimov, Albert L Waldo.   

Abstract

The canine sterile pericarditis model is characterized by impaired conduction and atrial arrhythmia vulnerability. Electrical and structural remodeling processes caused by the inflammatory response likely promote these abnormalities. In the present study, we tested the hypothesis that altered distribution of atrial connexins is associated with markedly abnormal atrial conduction, thereby contributing to vulnerability to atrial flutter (AFL) and atrial fibrillation (AF) induction and maintenance. During rapid pacing and induced, sustained AFL or AF in five sterile pericarditis (SP) and five normal (NL) dogs, epicardial atrial electrograms were recorded simultaneously from both atria (380 electrodes) or from the right atrium (RA) and Bachmann's bundle (212 electrodes). Tissues from RA sites were subjected to immunostaining and immunoblotting to assess connexin (Cx) 40 and Cx43 distribution and expression. Transmural myocyte (alpha-actinin) and fibroblast (vimentin) volume were also assessed by immunostaining. RA pacing maps showed markedly abnormal conduction in SP, with uniform conduction in NL. Total RA activation time was significantly prolonged in SP vs. NL at 300-ms and 200-ms pacing-cycle lengths. Sustained arrhythmias were only inducible in SP [total: 4/5 (AFL: 3/5; AF: 1/5)]. In NL, Cx40, Cx43, alpha-actinin, and vimentin were homogeneously distributed transmurally. In SP, Cx40, Cx43, and alpha-actinin were absent epicardially, decreased midmyocardially, and normal endocardially. SP increased epicardial vimentin expression, suggesting fibroblast proliferation. Immunoblot analysis confirmed reduced expression of Cx40 and Cx43 in SP. The transmural gradient in the volume fraction of Cx40 and Cx43 in SP is associated with markedly abnormal atrial conduction and is likely an important factor in the vulnerability to induction and maintenance of AFL/AF in SP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434983     DOI: 10.1152/ajpheart.00607.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  31 in total

1.  Selective molecular potassium channel blockade prevents atrial fibrillation.

Authors:  Guy Amit; Kan Kikuchi; Ian D Greener; Lizhu Yang; Victor Novack; J Kevin Donahue
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

2.  Radiofrequency catheter ablation versus balloon cryoablation of atrial fibrillation: markers of myocardial damage, inflammation, and thrombogenesis.

Authors:  Bor Antolič; Andrej Pernat; Marta Cvijić; David Žižek; Matevž Jan; Matjaž Šinkovec
Journal:  Wien Klin Wochenschr       Date:  2016-06-06       Impact factor: 1.704

Review 3.  Inflammation and the pathogenesis of atrial fibrillation.

Authors:  Yu-Feng Hu; Yi-Jen Chen; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  Nat Rev Cardiol       Date:  2015-01-27       Impact factor: 32.419

4.  Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model.

Authors:  Fadia Mayyas; Seiichiro Sakurai; Rashmi Ram; Julie H Rennison; Eui-Seock Hwang; Laurie Castel; Beth Lovano; Marie-Luise Brennan; Douglas Bibus; Bill Lands; John Barnard; Mina K Chung; David R Van Wagoner
Journal:  Cardiovasc Res       Date:  2010-11-30       Impact factor: 10.787

5.  Colchicine for the prevention of postoperative atrial fibrillation: a new indication for a very old drug?

Authors:  David R Van Wagoner
Journal:  Circulation       Date:  2011-11-22       Impact factor: 29.690

Review 6.  Connexin Remodeling Contributes to Atrial Fibrillation.

Authors:  Michelle M Jennings; J Kevin Donahue
Journal:  J Atr Fibrillation       Date:  2013-08-31

Review 7.  Post-operative Atrial Fibrillation - Pathophysiology, Treatment and Prevention.

Authors:  E Bidar; S Bramer; B Maesen; J G Maessen; U Schotten
Journal:  J Atr Fibrillation       Date:  2013-04-06

Review 8.  Primary Prevention of Atrial Fibrillation where are we in 2012?

Authors:  Massimo Imazio
Journal:  J Atr Fibrillation       Date:  2012-08-20

9.  Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.

Authors:  Tomonori Igarashi; J Emanuel Finet; Ayano Takeuchi; Yoshihisa Fujino; Maria Strom; Ian D Greener; David S Rosenbaum; J Kevin Donahue
Journal:  Circulation       Date:  2011-12-08       Impact factor: 29.690

Review 10.  Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance.

Authors:  Irene Savelieva; Antonios Kourliouros; John Camm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-25       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.